Xiaojia Wang - Concepedia

Author

Xiaojia Wang

Also Known As

Wang Xiaojia, X. WANG, XIAO-JIA WANG, XIAOJIA WANG, Xiao-Jia WANG, Xiao-Jia Wang, Xiao-jia Wang, Xiaojia Wang, Yueyin Pan, Yun Gao

284

Publications

Citations

H-Index

Concepts

All Affiliations

Zhejiang Cancer Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Harbin Medical University Sun Yat-sen University Third Affiliated Hospital of Harbin Medical University

About

Xiaojia Wang is an author at Zhejiang Cancer Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	2.9K
2	Health Sciences	7	7	1.8K
3	Engineering	3	3	172
4	Natural Sciences	1	1	14
5	Public Health	1	1	20

Xiaojia Wang

Publications

Citations

H-Index

Page 1

	Year	Citations
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer Shanu Modi, William Jacot, Toshinari Yamashita, New England Journal of Medicine	2022	2.3K
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study Sandra M. Swain, David Miles, Sung‐Bae Kim, The Lancet Oncology End-of-study ResultsBreast OncologyMedicineClinical TrialsPathology	2020	854
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Miguel Martín, Frankie A. Holmes, Bent Ejlertsen, The Lancet Oncology 5-Year AnalysisBreast OncologyOncologyHealth SciencesClinical Trials	2017	578
circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis Jianzhen Xu, Changchun Shao, Xiaojia Wang, Cell Death and Disease	2019	290
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer Xichun Hu, Jian Zhang, Binghe Xu, International Journal of Cancer	2014	267
EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells Weidong Han, Hongming Pan, Yan Chen, PLoS ONE ImmunologyCell DeathCancer BiologyTumor BiologyDrug Resistance	2011	250
Beneficial effects of exercise and its molecular mechanisms on depression in rats Hang Zheng, Yanyou Liu, Wei Li, Behavioural Brain Research Physical ActivityStress HormonePsychiatryBeneficial EffectsExercise	2005	210
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial Binghe Xu, Qingyuan Zhang, Pin Zhang, Nature Medicine Breast OncologyMedicinePharmacologyBreast CancerPharmacotherapy	2021	152
Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells Peng Xiao, Xiaopeng Wan, Bijun Cui, OncoImmunology	2015	115
Pyrotinib plus capecitabine for human epidermal growth factor receptor 2-positive metastatic breast cancer after trastuzumab and taxanes (PHENIX): a randomized, double-blind, placebo-controlled phase 3 study Min Yan, Li Bian, Xichun Hu, Translational Breast Cancer Research Breast OncologyOncologyPlacebo-controlled Phase 3MedicineCancer Management	2020	99

Page 1